Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL)

from Cancer via ola Kala on Inoreader http://ift.tt/1UrrasB
via IFTTT